![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GENSCI IS CHINA'S MOST PROFITABLE BIOPHARMA CO
GENSCI IS CHINA'S MOST PROFITABLE BIOPHARMA CO
October 3, 2006
GeneScience Pharmaceuticals is the most profitable biopharma company in China. This was revealed by the data compiled and released by the Chinese official agency, the National Bureau of Statistics. BioSpectrum (http://www.biospectrumasia.com/content/021006CHN1768.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct